CD274 and angiosarcoma: Here, we present a case of an elderly patient with a PD-L1-negative, low TMB scalp angiosarcoma who had a complete response to PD-1 inhibition-based immunotherapy, highlighting the potential use of this therapy in this rare cutaneous malignancy.